Citations

Clear

4610 citation(s) found for "Lu, Brian".

Language Barriers as a Reported Cause of Prehospital Care Delay in Minnesota
Grow, Robert W., Sztajnkrycer, Matthew D. , Moore, Brian R.

Mayo Clinic

Prehospital Emergency Care | January 11, 2008 | Volume: 12 | Issue: 1 | Pages: 76-79

10.1080/10903120701709878 | PMID 18189182 Get It

Pathway analysis of primary central nervous system lymphoma
Personett, David, Baskerville, Karen A., Menke, David M. , Jaeckle, Kurt A. , Kreinest, Pamela, Edenfield, Brandy , Lai, Weil, Park, Peter J. , McKinney, Michael, Tun, Han W. , Zubair, Abba C. , O’Neill, Brian Patrick , Park, Peter J

Mayo Clinic

Blood | January 10, 2008 | Volume: 111 | Issue: 6 | Pages: 3200-3210

10.1182/blood-2007-10-119099 | PMID 18184868 Get It

Abstract Primary central nervous system (CNS) lymphoma (PCNSL) is a diffuse large B-cell lymphoma (DLBCL) confined to the CNS. A genome-wide gene expression comparison between PCNSL and non-CNS DLBCL was performed, the latter consisting of both nodal and extranodal DLBCL (nDLBCL and enDLBCL), to identify a “CNS signature.” Pathway analysis with the program SigPathway revealed that PCNSL is characterized notably by significant differential expression of multiple extracellular matrix (ECM) and adhesion-related pathways. The most significantly up-regulated gene is the ECM-related osteopontin (SPP1). Expression at the protein level of ECM-related SPP1 and CHI3L1 in PCNSL cells was demonstrated by immunohistochemistry. The alterations in gene expression can be interpreted within several biologic contexts with implications for PCNSL, including CNS tropism (ECM and adhesion-related pathways, SPP1, DDR1), B-cell migration (CXCL13, SPP1), activated B-cell subtype (MUM1), lymphoproliferation (SPP1, TCL1A, CHI3L1), aggressive clinical behavior (SPP1, CHI3L1, MUM1), and aggressive metastatic cancer phenotype (SPP1, CHI3L1). The gene expression signature discovered in our study may represent a true “CNS signature” because we contrasted PCNSL with wide-spectrum non-CNS DLBCL on a genomic scale and performed an in-depth bioinformatic analysis.
A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System
Swiglo, Brian A, Murad, M H, Schünemann, Holger J, Kunz, Regina, Vigersky, Robert A, Guyatt, Gordon H, Montori, Victor M, Montori, Víctor M. , Murad, M. Hassan , Schünemann, Holger J. , Swiglo, Brian A, Murad, M H, Schünemann, Holger J, Kunz, Regina, Vigersky, Robert A, Guyatt, Gordon H, Montori, Victor M, Murad, M Hassan , Montori, Victor M , Schünemann, Holger J

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | January 3, 2008 | Volume: 93 | Issue: 3 | Pages: 666-673

10.1210/jc.2007-1907 | PMID 18171699 Get It

Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders
Banwell, Brenda , Tenembaum, Sílvia , Lennon, Vanda A. , Ursell, E., Kennedy, J., Weinshenker, Brian G. , Lucchinetti, Claudia F. , Pittock, Sean J. , Bar‐Or, Amit , Pittock, S J , Weinshenker, Brian G

Mayo Clinic

Neurology | December 20, 2007 | Volume: 70 | Issue: 5 | Pages: 344-352

10.1212/01.wnl.0000284600.80782.d5 | PMID 18094334 Get It

Mineralocorticoid Signaling in Transition to Heart Failure With Normal Ejection Fraction
Shapiro, Brian P. , Owan, Theophilus , Mohammed, Selma F. , Krüger, Martina , Linke, Wolfgang A. , Burnett, John C. , Redfield, Margaret M. , Linke, Wolfgang A

Mayo Clinic

Hypertension | December 18, 2007 | Volume: 51 | Issue: 2 | Pages: 289-295

10.1161/hypertensionaha.107.099010 | PMID 18086943 Get It

Heart failure with normal ejection fraction occurs in elderly patients with hypertensive heart disease. We hypothesized that, in such patients, mineralocorticoid receptor activation accelerates the types of ventricular and vascular remodeling and dysfunction believed important in the transition to heart failure. We tested this hypothesis by administering deoxycorticosterone acetate (DOCA) without salt loading or nephrectomy to elderly dogs with experimental hypertension. Elderly dogs were made hypertensive by renal wrapping. After 5 weeks, dogs were randomly assigned to DOCA (1 mg/kg per day IM; old hypertensive [OH]+DOCA; n=11) or not (OH; n=11) for 3 weeks. At week 8, conscious echocardiography and hemodynamic assessment under anesthesia were performed. DOCA resulted in further increases in conscious blood pressure ( P <0.05) without increases in cardiac output or diastolic volume. In the conscious state, effective arterial elastance ( P <0.05) and systemic vascular resistance ( P =0.06) were increased, and systemic arterial compliance ( P <0.05) was decreased in OH+DOCA animals. After anesthesia, instrumentation, and autonomic blockade, blood pressure was lower, whereas left ventricular (LV) systolic elastance, LV diastolic stiffness, and ex vivo myofiber diastolic stiffness were increased in OH+DOCA animals. LV collagen was increased in OH+DOCA animals ( P <0.05 for all), but LV mass, LV brain natriuretic peptide, and titin isoform profiles were not. Neither aortic stiffness nor aortic structure was altered in OH+DOCA animals. These findings suggest that age and hypertensive heart disease enhance sensitivity to exogenous mineralocorticoid administration and that mineralocorticoid receptor activation could contribute to the transition to heart failure in elderly persons by promoting increases in LV diastolic and systolic stiffness.
Suppression of 11β-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis
Park, Frank , Pietrusz, Jennifer L., Jia, Guangfu, Netzel, Brian C., Liang, Mingyu , Liu, Yong , Singh, Ravinder J.

Mayo Clinic

Physiological Genomics | December 12, 2007 | Volume: 32 | Issue: 3 | Pages: 343-351

10.1152/physiolgenomics.00067.2007 | PMID 18073273 Get It

11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1), which regulates the local level of glucocorticoids, has been suggested to be involved in the development of obesity. A definitive functional role for 11β-HSD1 in adipogenesis, however, remains to be established. We developed 3T3-L1 cell lines stably transfected with a small hairpin RNA (shRNA) targeting 11β-HSD1. A shRNA containing two nucleotide substitutions was used as a control. Silencing of 11β-HSD1 substantially attenuated the accumulation of lipid droplets and the expression of adipogenesis marker genes, which was induced by a mixture containing either corticosterone or dexamethasone. Silencing of 11β-HSD1 increased the concentration of 11-dehydrocorticosterone in the culture supernatant but did not significantly affect the levels of corticosterone or dexamethasone. Translocation of glucocorticoid receptors to the nucleus in response to glucocorticoids was significantly attenuated by silencing 11β-HSD1. The number of cells entering the S phase of the cell cycle following the induction of adipogenesis was significantly reduced by silencing 11β-HSD1. 11β-HSD1 shRNA delivered by lentiviral vectors after the induction of differentiation, however, did not affect the progression of adipogenesis. These results indicate that 11β-HSD1 plays a significant functional role in the initiation of 3T3-L1 adipogenesis and provide new mechanistic insights into the role of 11β-HSD1 in the development of obesity and related diseases.
Comparison of Locked Volar Plating Versus Pinning and External Fixation in the Treatment of Unstable Intraarticular Distal Radius Fractures
Rizzo, Marco , Katt, Brian A., Carothers, Joshua T., Katt, Brian A.

Mayo Clinic

HAND | October 16, 2007 | Volume: 3 | Issue: 2 | Pages: 111-117

10.1007/s11552-007-9080-0 | PMID 18780086 Get It

Introduction We retrospectively compared the outcomes of open reduction and internal fixation (ORIF) with volar locking plate versus standard external fixation and percutaneous pinning in treating similar unstable distal radius fractures with a minimum 2-year follow-up. Methods The ORIF group included 41 patients with an average follow-up of 29 months. The external fixation group comprised 14 patients with an average follow-up of 33 months. Average age at presentation was 45 years in the external fixation group and 48 years in the ORIF group. The male/female ratios were 16:25 among the ORIF group and 6:8 in the external fixation group. The two groups were compared for clinical and functional outcomes measured by the disabilities of the arm, shoulder, and hand (DASH) score. Pain scores were similar. Radiographic measurements were also evaluated between groups. Results Final ranges of motion and grip strengths were similar between the two groups. The mean DASH score of the locked volar plate group was 9 compared to 23 for the external fixation group. Radiographically, volar tilt and radial length were significantly better in the patients treated with ORIF. The ORIF group required less therapy visits. No complications occurred in the locked volar plate group whereas two patients had pin tract infections and one had prolonged finger stiffness in the external fixation group. Conclusion Locked volar plating compares favorably to external fixation and pinning for amenable fracture patterns. Whereas grip and range-of-motion data were similar, DASH scores, frequency of rehabilitation, and some radiographic parameters were superior in patients treated with ORIF.
p27-p16 Fusion Gene Inhibits Angioplasty-Induced Neointimal Hyperplasia and Coronary Artery Occlusion
Tsui, Lisa, Camrud, Allan R., Mondesire, Jean, Carlson, Paula, Zayek, Nathalie, Camrud, Ladonna J., Donahue, Brian A., Lin, Andy, Frey, David , Rivkin, Marianne, Subramanian, Ajit, Falotico, Robert, Gyuris, Jenő, Schwartz, Robert S., McArthur, James G., Bauer, Scott R.

Mayo Clinic

Circulation Research | September 28, 2007 | Volume: 89 | Issue: 4 | Pages: 323-328

10.1161/hh1601.094482 | PMID 11509448 Get It

Inhibition of proliferative neointima formed by vascular smooth muscle cells is a potential target in preventing angioplasty-induced restenosis. We have created a potent antiproliferative by fusing the active regions of the p27 and p16 cell cycle inhibitors. Intravascular delivery of a replication-deficient adenoviral vector (AV) encoding this p27-p16 fusion protein, named W9, inhibited balloon injury–induced neointimal hyperplasia in rabbit carotid arteries. In a therapeutically more relevant model, AV-W9 was delivered to balloon-injured porcine coronary arteries in vivo using an infusion catheter. Of the three coronary arteries, two were injured with a 15-mm balloon catheter and either were left untreated or were treated with 10 12 viral particles of either AV-W9 or a control null virus. AV-W9 treatment significantly inhibited neointimal hyperplasia in this porcine arterial balloon injury model compared with untreated or control virus–treated vessels. The average intimal area of the AV-W9–treated group 10 days after balloon injury and treatment was 0.42±0.36 mm 2 , whereas the AV-null group demonstrated an intimal area of 0.70±0.52 mm 2 . At day 10 the average intimal thickness of the AV-W9–treated vessels was 9.1 μm (n=5, ×20 magnification) compared with 21.2 μm (n=5, ×20 magnification) in control virus–treated vessels. This trend was also observed at 28 days after balloon injury and gene transfer during which AV-W9–treated vessels demonstrated an average intimal thickness of 4.7 μm (n=8, ×20 magnification) compared with 13.3 μm (n=3, ×20 magnification) in control virus–treated vessels and 7.3 μm (n=5, ×20 magnification) in the sham-treated vessels. The AV-W9 treatment was safe and well tolerated. These data suggest that AV-W9 gene therapy may be useful in preventing angioplasty–induced intimal hyperplasia in the coronary artery.
End-of-procedure cefazolin concentrations after administration for prevention of surgical-site infection
Koopman, Erin, Erstad, Brian L. , Demeure, Michael J. , Hayes, Melinda M., Ruth, John T., Matthias, Kathryn R., Koopman, Erin M, Nix, David E.

Mayo Clinic

American Journal of Health-System Pharmacy | September 5, 2007 | Volume: 64 | Issue: 18 | Pages: 1927-1934

10.2146/ajhp070047 | PMID 17823104 Get It

Practice Abstracts
Denton, Brian T.

Mayo Clinic

Interfaces | August 7, 2007 | Volume: 37 | Issue: 4 | Pages: 353-354

10.1287/inte.1060.0247 Get It

The goal of “Practice Abstracts” is to present interesting, topical, and novel applications of operations research methodology to a wide range of industrial applications. “Practice Abstracts” are intended to provide Interfaces readers with short (2–4 page) descriptions of the most relevant aspects of operations research-based projects, in a form that is accessible to academics and practitioners in other organizations. Contributions should be sent for evaluation to the editor of “Practice Abstracts,” Brian T. Denton, Division of Health Care Policy and Research, Pavilion 3, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, denton.brian@mayo.edu.